‘The Retrievals' Season 2 Is Out Now
Hi, I'm the host of 'The Retrievals.' Season 2 launches today! It's about C-sections. We begin at a Chicago hospital where staff members decide to take action after one of their nurses undergoes an excruciating C-section.
If you heard Season 1, you'll know that it identified a problem: Women's pain is often ignored. The second season asks: What are the solutions?
Season 2 grows directly out of listener responses to Season 1, so today I want to tell you about those responses and how they shaped my reporting.
Two years ago, after the first season of 'The Retrievals,' I received hundreds of messages from listeners. They wrote about many varieties of pain. Many varieties of not being listened to. Many varieties of birth trauma. They wrote about experiences that had happened one year ago, or nearly 50.
I wanted to keep track of these stories. So I started a spreadsheet, with names and dates and subjects. Maybe there would be a pattern that emerged. An observation that would lead to more reporting. Or maybe the spreadsheet wouldn't lead to an output or to an outcome. Maybe it was just a private way of honoring the respondents.
When you read just a handful of the cells together, they have a distilled emotional power. Here's a sample, all from a single week in August 2023:
Want all of The Times? Subscribe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Suspected gunman in CDC shooting had grievance toward Covid vaccine: Sources
The man suspected of opening fire on the Centers for Disease Control and Prevention's sprawling campus late Friday had blamed the COVID-19 vaccine for making him sick and depressed, according to information gathered by law enforcement and sources close to the suspect. The investigation remains ongoing, and officials caution that the information is preliminary at this time. Patrick White is believed to have struggled with his mental health, according to that information. As he grappled with those issues, sources said, White had become increasingly fixated on the COVID-19 vaccine as a source of his grievances. Several Kennesaw residents who knew the 30-year-old suspected shooter told ABC News they had heard White express similar angry and conspiracy-minded sentiments. MORE: Officer killed, suspect identified in shooting near CDC headquarters, Emory University campus One neighbor, who asked not to be named, said White would sit on her porch for long stretches, often complaining that after he got the COVID-19 shot, he had lost a lot of weight, developed problems swallowing and gastrointestinal issues. And, the neighbor said he believed the media and government weren't covering it. "He thought the vaccines were killing him and that people needed to know the truth," the neighbor said, adding that she didn't agree with him, but would listen. White's father declined to comment on his son when reached by ABC News. The Georgia Bureau of Investigation, which is leading the probe, declined to comment on a potential motive. Infectious disease experts maintain that mRNA vaccines like those used against COVID-19 have been studied for decades and that the shots were instrumental in saving lives during the COVID-19 pandemic, according to the CDC. Though the COVID-19 vaccines have been highly politicized and subject to a deluge of mis and disinformation, experts say they are safe and effective. Long-term adverse reactions to the COVID-19 vaccines are generally very rare, according to the CDC. All CDC employees nationwide, except for essential on-site personnel, have been instructed to work remotely on Monday as Georgia investigators continue probing Friday's deadly active shooter incident near the agency's Atlanta headquarters, according to a letter obtained by ABC News. MORE: 1 dead, 5 wounded, including 5-year-old girl, in Baltimore 'mass shooting': Police In the letter, CDC leadership told the agency's more than 10,000 employees that both federal and local law enforcement are conducting "intensive monitoring of all potential threats to CDC and its staff, current and past" to ensure their safety. Investigators have yet to reveal the motive behind Friday's shooting, but the CDC leadership said in the email, "What we know about the incident is that this was a targeted attack on CDC related to COVID." DeKalb County Police Officer David Rose was fatally shot after responding to the reported gunfire. He was taken to the hospital in critical condition, where he was pronounced dead, officials said at a press conference Friday evening. During the shooting, the suspect fired multiple rounds at CDC buildings, breaking windows, Atlanta Police Chief Darin Schierbaum said during a press conference. In the aftermath of the shooting, four other people were transported to an area hospital for stress and anxiety-related reasons, the police chief said.
Yahoo
35 minutes ago
- Yahoo
Sophie Grégoire Trudeau says there's 'no shame' in talking about sex during menopause. Here's what a doctor wants you to know
The 50-year-old author and mental health advocate didn't shy away from a "risqué" topic during a recent social media video. Sophie Grégoire Trudeau is empowering women to take control of their bodies and their health during menopause. Earlier this week, the former television host took to social media to share a message with her followers about an encounter with a woman following a yoga class. According to Grégoire Trudeau, the woman asked her to discuss a "risqué" topic with her more than 369,000 followers on Instagram: sex during menopause. "Risqué? More like real-squé," the 50-year-old author joked. "There is no shame talking about this because during menopause our relationship with intimacy shifts not just physically but emotionally and psychologically — and even I would say, spiritually." This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle. Grégoire Trudeau continued by noting that many women experience vaginal dryness, changes in libido as well as discomfort that "nobody warned us about." Others may view menopause as a time to "reclaim" their bodies after "years of roles and expectations." "But here's the truth — these changes are common and are part of a transition process, a transition phase that can be manageable," she said. The wellness expert and mental health advocate encouraged followers to speak to their healthcare providers about options to alleviate the symptoms of menopause, including hormone therapies or pelvic floor therapy. "These aren't just medical options they're conversations about quality of life, connection to your own body," Grégoire Trudeau continued. "Don't be intimidated to ask. Our bodies as women will only open up and blossom if we feel connected and safe physically and emotionally." While there's the common misconception that women become less sexual during menopause, Grégoire Trudeau encouraged women to rethink the possibilities for their life during and post menopause. "Menopause doesn't have to be the end of our erotic world and language and sexuality," she said. "It can be the beginning of a more honest and fulfilling relationship own language with our bodies." The post was met by praise from followers who appreciated Grégoire Trudeau taking on what many may consider a taboo topic. "I remember hitting menopause and wanting to talk about these things with girlfriends, and no one wanted to go there," a follower said. "But unless we talk about it, we can't discover solutions or learn a few tips." "Thank you! Thank you! Thank you! You've started such an important conversation and with such grace and thoughtfulness," another added. "...This conversation is so important and you are amazing for speaking about it," someone said. "Honestly I've only ever heard you and Halle Berry speak on this topic publicly and openly. A lot of women have zero information on any of this and it's really damaging." While there's been more talk of menopause and the life-changing symptoms it brings, for many women, it still remains a subject shrouded in mystery. Dr. Sheila Wijayasinghe, a family physician at St. Michael's Hospital in Toronto, who is committed to rewriting the narrative surrounding menopause by raising awareness about the sexual changes they may experience and providing expert advice on how to navigate it with confidence. "As individuals transition through perimenopause into menopause, they experience just a myriad of changes that can significantly impact their sexual function that really, is multifactorial," Wijayasinghe said in a previous interview with Yahoo Canada. Wijayasinghe explained that these changes are rooted in hormonal fluctuations, primarily involving estrogen, progesterone and testosterone. Addressing the elephant in the room: Vaginal dryness While loss of libido and vaginal dryness are two primary issues that impact women's sexual health during menopause, they're also two of the most challenging things to address with a healthcare professional due to stigma. "It's not something that patients will necessarily bring up as a first comment. But I'll notice it when I'm about to prepare to do a pap test," Wijayasinghe said, adding that vaginal dryness is one of the "key symptoms" she manages at her primary care office. Vaginal dryness is one of the vaginal health symptoms included in genitourinary syndrome of menopause (GSM), an umbrella term that can also include burning and stinging (dysuria), frequent urge to urinate reccurring urinary tract infections. Wijayasinghe explained how vaginal dryness can "make sexual activity uncomfortable and painful" and can not only impact someone's quality of life, but also the quality of relationships. In terms of libido, she says that while many people might notice a decrease in libido due to lower levels of estrogen and testosterone, others may experience the opposite; a sexual awakening. "Some people actually notice when they transition through to menopause, an increase in libido and increase in arousal because they actually feel more confident in themselves, they are free from periods, they're not worried about getting pregnant," Wijayasinghe said. What to do when menopause symptoms impact your sex life Wijayasinghe said "communication is lubrication" when it comes to sexual health. Acknowledging that there are changes happening and then communicating them with your partner can "foster intimacy and lead to a better understanding of each other's needs." Candid communication with your healthcare provider is also important in finding the best course of action in treating menopausal symptoms. "It can be really scary to discuss this, but there are solutions that are available that can help improve your overall well being, your quality of life, and your sexual health," Wijayasinghe said. "...Exercise, proper sleep, mindfulness, relaxation techniques can all help manage stress, improve our mood, improve our self-esteem, our physical health and enhance sexual well-being," she said. "Perhaps considering exploring new avenues of intimacy, where you have a little bit of fun with it, experiment with different ways to connect sexually and emotionally."
Yahoo
an hour ago
- Yahoo
3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August
Key Points Merck is an industry giant that has proved time and again it can innovate for the future. Ventas has positioned itself to grow its business and its dividend. Omega Healthcare Investors has survived the storm, and now it is ready to ride the wave. 10 stocks we like better than Merck › If you are looking at healthcare stocks for dividend ideas in August, don't get too caught up on the sector's low 1.8% dividend yield. You can do much better than that without having to take on huge risks. Three solid options that you might want to buy hand over fist right now are Merck (NYSE: MRK), Ventas (NYSE: VTR), and Omega Healthcare Investors (NYSE: OHI). Here's a primer on each one. 1. Merck is a high-yield survivor Merck's dividend yield is a pleasing 4.1% or so, more than twice the healthcare sector's average. The company has increased its payout annually for 15 consecutive years. From this standpoint, it is an attractive dividend stock, but what about the business? Merck is one of the world's largest pharmaceutical companies. Discovering new drugs is hard work, and it usually doesn't happen in a linear fashion. Right now, investors appear concerned that Merck's current patents will expire before it finds a new blockbuster to replace its older drugs. That's not unreasonable, since it is highly reliant on the revenue of just one drug right now (oncology treatment Keytruda). But this isn't an unusual development; it is kind of normal for drug companies to go through periods like this. What's important to note is that Merck's strong research and development capabilities and its scale (it can fairly easily buy smaller companies to bolster its drug pipeline if it needs to) have allowed it to thrive over the long term. And that has allowed the dividend to trend reliably higher for decades, though it has not increased every single year. If you can handle buying while others are selling, Merck looks like an attractive choice right now. Its yield is near the highest levels since the Great Recession. 2. Ventas cut its dividend, but now it's set to grow Ventas is a real estate investment trust (REIT) specializing in senior housing, with a dividend yield of 2.8%. That's not bad, but it's not exactly an earth-shattering figure. And on top of that, the REIT cut its dividend during the pandemic. It was the right move, given that senior housing facilities were particularly hard hit during that time. And the dividend cut allowed Ventas to work with its tenants and shift its business approach in a more growth-focused direction. Specifically, Ventas increased its exposure to properties that it both owns and operates (technically, it hires a property manager). This allows the revenue and costs to flow directly onto the income statement. When times are tough, like during the pandemic, that's bad news. When times are flush, however, these assets can supercharge earnings. Senior housing has come back strongly from the pandemic hit. And the aging demographics of the country suggest there's more growth to come. The big story, however, is that dividend increases have resumed. And given the growth-focused nature of the business right now -- adjusted funds from operations rose a heady 9% year over year in the second quarter -- it is reasonable to expect dividend raises to be quite attractive in the years ahead. 3. Omega Healthcare Investors is still out of favor Omega Healthcare's dividend yield is a lofty 6.7%. The payout hasn't been increased in years, but it also hasn't been cut. Like Ventas, Omega is a REIT that owns senior housing properties, and they were hard hit during the pandemic. Omega chose to hold the line on its dividend as it worked with its tenants. The portfolio repositioning has been difficult, but now that the world has mostly moved past the pandemic, things are starting to improve. Adjusted FFO rose around 8% in the second quarter. That strong showing isn't quite as big an opportunity on the dividend front here, however, because its payout remained high throughout the pandemic period. But it is a sign that Omega's payout is likely sustainable as it gets back on the growth track, including buying new properties. Ventas' exposure to senior housing and the graying of the country are growth engines. Omega's exposure to this same thing is a recovery engine. If you need income today, buying into its turnaround story will probably be more attractive to you than buying Ventas. Three solid dividend choices in the healthcare sector Even when the average healthcare stock has a miserly 1.8% yield, you can still find very attractive income options. Merck is a tried-and-true dividend payer with a well-run business and attractive yield. Ventas, which also has an attractive yield, repositioned itself for growth during the pandemic, and that is now starting to shine through on the dividend side of things. And Omega muddled through the pandemic without a dividend cut, leaving it with a high yield today and a strengthening business. August could be a great time to buy one or more of these healthcare dividend stocks. Should you buy stock in Merck right now? Before you buy stock in Merck, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Merck wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Merck. The Motley Fool has a disclosure policy. 3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August was originally published by The Motley Fool
